Feasibility and acceptability of Problem Management Plus (PM+) among Syrian refugees and asylum seekers in Switzerland: a mixed-method pilot randomized controlled trial.

Julia Spaaij ORCID logo; Nikolai Kiselev ORCID logo; ChristineBerger; Richard ABryant; Pim Cuijpers ORCID logo; Anne M de Graaff ORCID logo; Daniela C Fuhr ORCID logo; MahmoudHemmo; David McDaid ORCID logo; Hanspeter Moergeli ORCID logo; +7 more... A-La Park ORCID logo; Monique C Pfaltz ORCID logo; Matthis Schick ORCID logo; Ulrich Schnyder ORCID logo; AnnaWenger; Marit Sijbrandij ORCID logo; Naser Morina ORCID logo; (2022) Feasibility and acceptability of Problem Management Plus (PM+) among Syrian refugees and asylum seekers in Switzerland: a mixed-method pilot randomized controlled trial. European Journal of Psychotraumatology, 13 (1). 2002027-. ISSN 2000-8066 DOI: 10.1080/20008198.2021.2002027
Copy

BACKGROUND: Syrian refugees in Switzerland face several barriers in accessing mental health care. Cost-effective psychological interventions are urgently needed to meet the mental health needs of refugees. Problem Management Plus (PM+) is an evidence-based, psychological intervention delivered by trained non-specialist 'helpers'. OBJECTIVE: To assess the feasibility and acceptability of PM+ among Syrian refugees in Switzerland. METHODS: We conducted a single-blind pilot randomized controlled trial (RCT) with Syrian refugees impaired by psychological distress (K10 > 15 and WHODAS 2.0 > 16). Participants were randomized to PM+ or Enhanced Treatment As Usual (ETAU). Participants were assessed at baseline, and 1 week and 3 months after the intervention, and completed measures indexing mental health problems and health care usage. Semi-structured interviews were conducted with different stakeholders. RESULTS: N = 59 individuals were randomized into PM+ (n = 31) or ETAU (n = 28). N = 18 stakeholders were interviewed about facilitators and barriers for the implementation of PM+. Retention rates in the trial (67.8%) and mean intervention attendance (M = 3.94 sessions, SD = 1.97) were high. No severe events related to the study were reported. These findings indicate that the trial procedures and PM+ were feasible, acceptable and safe. CONCLUSIONS: The findings support the conduct of a definitive RCT and show that PM+ might have the potential to be scaled-up in Switzerland. The importance, as well as the challenges, of implementing and scaling-up PM+ in high-income countries, such as Switzerland, are discussed.



picture_as_pdf
Spaaij_etal_2022_Feasibility-and-acceptability-of-problem.pdf
subject
Published Version
Available under Creative Commons: NC 4.0

View Download

Explore Further

Read more research from the creator(s):

Find work associated with the faculties and division(s):

Find work from this publication: